Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Insulin Resistance
82%
Insulin
63%
Type 2 Diabetic Patients
44%
Insulin Receptor Substrate 1 (IRS1)
44%
Japanese Patients
38%
Japanese Population
35%
Ipragliflozin
34%
IRS2
32%
STELLA
30%
Mitogen-activated Protein Kinase
29%
High-fat Diet
28%
Tyrosine Phosphorylation
26%
Adipose Tissue
26%
Lung Cancer
25%
Phosphoinositide 3-kinase (PI3K)
24%
Obesity
24%
Diabetes
23%
Non-small Cell Lung Cancer (NSCLC)
23%
Post-marketing Surveillance
23%
Old Japanese
23%
Adiponectin
22%
Peroxisome Proliferator-activated Receptor
22%
Gene-deficient Mice
22%
Insulin Receptor
21%
Liver
21%
Macrophages
21%
Subgroup Analysis
20%
Single nucleotide Polymorphism
20%
Older Men
19%
Adipocyte
19%
Body Mass Index
18%
Homozygous Familial Hypercholesterolemia (HoFH)
18%
Insulin Sensitivity
17%
Metabolic Syndrome
17%
Growth Factors
16%
Hemoglobin A1c (HbA1c)
16%
Tumor Necrosis Factor-α
16%
Myocytes
16%
Insulin Signaling
15%
Phosphorylation
15%
Insulin-like
15%
Impaired Glucose Tolerance
15%
Chemotherapy
15%
Japanese Workers
14%
Visceral Adipose Tissue
14%
Asthma
14%
Gut Microbiota
14%
Japan
14%
Sirtuin 1 (SIRT1)
13%
Monotherapy
13%
Glucose Metabolism
12%
3T3-L1 Adipocytes
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Protein Kinase
11%
Fasting Plasma Glucose
11%
Chest Pain
11%
Tyrosine
11%
Older Women
11%
Chest Radiograph
10%
Polymorphism
10%
Rheumatoid Arthritis
10%
Adverse Drug Reaction
10%
High-density Lipoprotein Cholesterol (HDL-C)
10%
Adipose Tissue Macrophages
10%
Alanine Aminotransferase
10%
Progression-free Survival
10%
IgG4-related Disease (IgG4-RD)
10%
Serum Adiponectin
9%
Type 2 Diabetes Mellitus Patients
9%
Hypoxia
9%
Serum Levels
9%
M2 Macrophages
9%
Diabetic Patients
9%
Chest CT
9%
Kinase Activity
9%
Long-term Efficacy
9%
CD206
9%
Elderly Patients
9%
Small Cell Lung Cancer
8%
Insulin Receptor Kinase
8%
Tyrosine Kinase Activity
8%
Diet-induced Obese Mice
8%
Triglycerides
8%
Risk Factors
8%
Epidermal Growth Factor
8%
Chinese Hamster Ovary Cells
8%
Japanese Subjects
8%
Replication Study
8%
Clinical Characteristics
8%
Vascular Endothelial Growth Factor
8%
Lung Adenocarcinoma
8%
Insulin Action
8%
Waist Circumference
8%
Astaxanthin
8%
SIRT1 Activator
8%
Autism Spectrum Disorder
8%
Cholesteryl Ester Transfer Protein Deficiency
8%
Non-elderly
8%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
8%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
64%
Insulin Resistance
62%
Adipocyte
41%
Kinase
29%
Phosphotransferase
29%
Mitogen-Activated Protein Kinase
28%
Single-Nucleotide Polymorphism
26%
Adiponectin
25%
Phosphoinositide 3-Kinase
23%
Tyrosine Phosphorylation
22%
Macrophage
19%
Peroxisome Proliferator-Activated Receptor
18%
Tyrosine
17%
Receptor Tyrosine Kinase
16%
Cardiac Muscle Cell
16%
Insulin Sensitivity
16%
Glucose Blood Level
15%
Impaired Glucose Tolerance
14%
Protein Kinases
14%
Blood Plasma
13%
Tyrosine Kinase
13%
Allele
12%
Triglyceride
12%
Cell Function
12%
Glucose Transport
12%
Insulin Release
11%
Signal Transduction
11%
3T3-L1
11%
T Cell
11%
Glucose Metabolism
10%
Synapsin I
10%
Genetics
10%
Sirtuin1
10%
Insulin-Like Growth Factor 1
9%
Genome-Wide Association Study
9%
Tumor Necrosis Factor
9%
Genotyping
9%
Genetic Divergence
9%
Insulin Signaling
9%
Preadipocyte
8%
HDL-Cholesterol
8%
Body Mass
8%
Mouse Mutant
8%
Mitochondrial Membrane Transport Protein
8%
Carrier Protein
8%
Chinese Hamster
8%
Familial Hypercholesterolemia
8%
Cholesteryl Ester
8%
Vascular Endothelial Growth Factor
7%
Cytokine
7%
Prevalence
7%
Knockout Mouse
7%
Intestine Flora
7%
C-Fos
7%
Genetic Variation
7%
Transgenic Mouse
7%
Epidermal Growth Factor
7%
Epidermal Growth Factor Receptor
7%
Case-Control Study
7%
Messenger RNA
6%
Fibroblast
6%
Osteoclastogenesis
6%
Glucose Tolerance Test
6%
Glucose Test
6%
Gene Expression
6%
Secretion (Process)
6%
Adipose Tissue Macrophages
6%
Pioglitazone
6%
Autoantibodies
6%
Angiotensin
6%
Hypertriglyceridemia
6%
Myeloid
6%
Cancer Cell
6%
Osteoclast
6%
Genetic Background
6%
Reoxygenation
6%
Blood Level
5%
C-Terminus
5%
Dyslipidemia
5%
Wild Type
5%
Downregulation
5%
Wild Type Mouse
5%
IRS1
5%
Autophosphorylation
5%
Genetic Risk
5%
Glucagon
5%
C-Peptide
5%
Waist Circumference
5%
Gene Mutation
5%
Single Nucleotide Polymorphism
5%
RANKL
5%
Growth Hormone
5%
Bovine Somatotropin
5%
Enzyme
5%
Astaxanthin
5%
Cell Growth
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
45%
Insulin Resistance
27%
Lung Cancer
24%
Diabetes
23%
Diabetes Mellitus
19%
Chemotherapy
16%
Peroxisome Proliferator Activated Receptor
15%
Adipose Tissue
15%
Disease
14%
Thorax Radiography
14%
High Fat Food
13%
Patient with Type 2 Diabetes
13%
Non Small Cell Lung Cancer
13%
Gut Microbiota
12%
Rheumatoid Arthritis
12%
Inflammatory Arthritis
12%
Lung
12%
Metabolic Syndrome
11%
Adipocyte
11%
Small Cell Lung Cancer
10%
Sirtuin1
10%
Asthma
9%
Insulin Dependent Diabetes Mellitus
9%
Thorax Pain
9%
Immune Checkpoint Inhibitor
9%
Immunoglobulin G4
9%
Diet Induced Obesity
9%
Pulmonary Hypertension
8%
Monotherapy
8%
Lung Adenocarcinoma
8%
Disease Course
8%
Hemoglobin A1c
8%
Ipragliflozin
8%
Subgroup Analysis
8%
Familial Hypercholesterolemia
8%
Body Mass Index
8%
Glucose Metabolism
7%
Triacylglycerol
7%
Systemic Lupus Erythematosus
7%
Macrophage
7%
Retrospective Study
7%
Cell Function
6%
Transgenic Mouse
6%
Prednisolone
6%
IgG4-Related Disease
6%
Neoplasm
6%
Metastatic Carcinoma
6%
Coughing
6%
Adiponectin
6%
Insulin Receptor
6%
Body Weight
5%
Pleura Effusion
5%
Biopsy Technique
5%
Tumor Necrosis Factor
5%
C-Peptide
5%
Gut Microbiome
5%
Rituximab
5%
Computer Assisted Tomography
5%
Insulin Signaling
5%
T Cell
5%
Receptor
5%
Recurrent Disease
5%
Dyspnea
5%
Middle Age
5%
Single Nucleotide Polymorphism
5%
Phosphoinositide 3-Kinase
5%
Observational Study
5%